These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 25740570)

  • 1. Bone cells and bone turnover in diabetes mellitus.
    Rubin MR
    Curr Osteoporos Rep; 2015 Jun; 13(3):186-91. PubMed ID: 25740570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal fragility in diabetes.
    Rubin MR
    Ann N Y Acad Sci; 2017 Aug; 1402(1):18-30. PubMed ID: 28926113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulated serum sclerostin level in the T2DM patients with femur fracture inhibits the expression of bone formation/remodeling-associated biomarkers via antagonizing Wnt signaling.
    Wu Y; Xu SY; Liu SY; Xu L; Deng SY; He YB; Xian SC; Liu YH; Ni GX
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):470-478. PubMed ID: 28239825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of bone turnover and bone quality in type 2 diabetic bone disease: current concepts and future directions.
    Rubin MR; Patsch JM
    Bone Res; 2016; 4():16001. PubMed ID: 27019762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fracture Risk Assessment in Patients With Diabetes Mellitus.
    Poiana C; Capatina C
    J Clin Densitom; 2017; 20(3):432-443. PubMed ID: 28716499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Diabetes on Bone Material Properties.
    Lekkala S; Taylor EA; Hunt HB; Donnelly E
    Curr Osteoporos Rep; 2019 Dec; 17(6):455-464. PubMed ID: 31713179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone Structure and Predictors of Fracture in Type 1 and Type 2 Diabetes.
    Starup-Linde J; Lykkeboe S; Gregersen S; Hauge EM; Langdahl BL; Handberg A; Vestergaard P
    J Clin Endocrinol Metab; 2016 Mar; 101(3):928-36. PubMed ID: 26756117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone damage in type 2 diabetes mellitus.
    Carnevale V; Romagnoli E; D'Erasmo L; D'Erasmo E
    Nutr Metab Cardiovasc Dis; 2014 Nov; 24(11):1151-7. PubMed ID: 25150773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct effects of pioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitus.
    van Lierop AH; Hamdy NA; van der Meer RW; Jonker JT; Lamb HJ; Rijzewijk LJ; Diamant M; Romijn JA; Smit JW; Papapoulos SE
    Eur J Endocrinol; 2012 Apr; 166(4):711-6. PubMed ID: 22267280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into bone fragility in diabetes: the crucial role of bone quality on skeletal strength.
    Yamamoto M
    Endocr J; 2015; 62(4):299-308. PubMed ID: 25797364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of diabetes mellitus-induced bone fragility.
    Napoli N; Chandran M; Pierroz DD; Abrahamsen B; Schwartz AV; Ferrari SL;
    Nat Rev Endocrinol; 2017 Apr; 13(4):208-219. PubMed ID: 27658727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biochemical markers of bone turnover. New aspect. Bone metabolic markers available in daily practice].
    Wada S; Fukawa T; Kamiya S
    Clin Calcium; 2009 Aug; 19(8):1075-82. PubMed ID: 19638690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sclerostin levels and changes in bone metabolism after bariatric surgery.
    Muschitz C; Kocijan R; Marterer C; Nia AR; Muschitz GK; Resch H; Pietschmann P
    J Clin Endocrinol Metab; 2015 Mar; 100(3):891-901. PubMed ID: 25490275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of bone turnover to bone density and fractures.
    Melton LJ; Khosla S; Atkinson EJ; O'Fallon WM; Riggs BL
    J Bone Miner Res; 1997 Jul; 12(7):1083-91. PubMed ID: 9200008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers of bone health and osteoporosis risk.
    Eastell R; Hannon RA
    Proc Nutr Soc; 2008 May; 67(2):157-62. PubMed ID: 18412989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between bone formation markers bone alkaline phosphatase, osteocalcin and amino-terminal propeptide of type I collagen and bone mineral density in elderly men. Preliminary results.
    Lumachi F; Orlando R; Fallo F; Basso SM
    In Vivo; 2012; 26(6):1041-4. PubMed ID: 23160690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sclerostin Regulation, Microarchitecture, and Advanced Glycation End-Products in the Bone of Elderly Women With Type 2 Diabetes.
    Piccoli A; Cannata F; Strollo R; Pedone C; Leanza G; Russo F; Greto V; Isgrò C; Quattrocchi CC; Massaroni C; Silvestri S; Vadalà G; Bisogno T; Denaro V; Pozzilli P; Tang SY; Silva MJ; Conte C; Papalia R; Maccarrone M; Napoli N
    J Bone Miner Res; 2020 Dec; 35(12):2415-2422. PubMed ID: 32777114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical bone turnover markers in diabetes mellitus - A systematic review.
    Starup-Linde J; Vestergaard P
    Bone; 2016 Jan; 82():69-78. PubMed ID: 25722065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 diabetes and bone.
    Leslie WD; Rubin MR; Schwartz AV; Kanis JA
    J Bone Miner Res; 2012 Nov; 27(11):2231-7. PubMed ID: 23023946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated sclerostin levels are associated with vertebral fractures in patients with type 2 diabetes mellitus.
    Yamamoto M; Yamauchi M; Sugimoto T
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4030-7. PubMed ID: 23894157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.